1. Home
  2. LPAA vs VSTM Comparison

LPAA vs VSTM Comparison

Compare LPAA & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPAA
  • VSTM
  • Stock Information
  • Founded
  • LPAA 2024
  • VSTM 2010
  • Country
  • LPAA United States
  • VSTM United States
  • Employees
  • LPAA N/A
  • VSTM N/A
  • Industry
  • LPAA
  • VSTM Biotechnology: Pharmaceutical Preparations
  • Sector
  • LPAA
  • VSTM Health Care
  • Exchange
  • LPAA Nasdaq
  • VSTM Nasdaq
  • Market Cap
  • LPAA 289.2M
  • VSTM 239.9M
  • IPO Year
  • LPAA 2024
  • VSTM 2012
  • Fundamental
  • Price
  • LPAA $10.07
  • VSTM $5.39
  • Analyst Decision
  • LPAA
  • VSTM Strong Buy
  • Analyst Count
  • LPAA 0
  • VSTM 8
  • Target Price
  • LPAA N/A
  • VSTM $12.43
  • AVG Volume (30 Days)
  • LPAA 44.1K
  • VSTM 2.4M
  • Earning Date
  • LPAA 01-01-0001
  • VSTM 03-13-2025
  • Dividend Yield
  • LPAA N/A
  • VSTM N/A
  • EPS Growth
  • LPAA N/A
  • VSTM N/A
  • EPS
  • LPAA N/A
  • VSTM N/A
  • Revenue
  • LPAA N/A
  • VSTM $10,000,000.00
  • Revenue This Year
  • LPAA N/A
  • VSTM N/A
  • Revenue Next Year
  • LPAA N/A
  • VSTM $117.91
  • P/E Ratio
  • LPAA N/A
  • VSTM N/A
  • Revenue Growth
  • LPAA N/A
  • VSTM N/A
  • 52 Week Low
  • LPAA $9.66
  • VSTM $2.10
  • 52 Week High
  • LPAA $10.07
  • VSTM $14.22
  • Technical
  • Relative Strength Index (RSI)
  • LPAA N/A
  • VSTM 53.22
  • Support Level
  • LPAA N/A
  • VSTM $5.08
  • Resistance Level
  • LPAA N/A
  • VSTM $6.02
  • Average True Range (ATR)
  • LPAA 0.00
  • VSTM 0.68
  • MACD
  • LPAA 0.00
  • VSTM -0.06
  • Stochastic Oscillator
  • LPAA 0.00
  • VSTM 50.79

About LPAA Launch One Acquisition Corp. Class A Ordinary shares

Launch One Acquisition Corp is a blank check company.

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Share on Social Networks: